Rare Mom Steps Up to the Plate and Hits it Out of the Park for GT Research
Julia Smith was diagnosed with Glanzmann thrombasthenia (GT) at the tender young age of six months through a series of fortunate events. First, her mother Helen,
The Glanzmann’s Research Foundation
The Glanzmann’s Research Foundation
The Glanzmann’s Research Foundation exists to increase awareness of Glanzmann’s Thrombasthenia, provide a network of support for families navigating through a GT diagnosis, and raise funding to find a cure.
If you have found the GRF because you or a loved one have recently been diagnosed with GT, we want to let you know that you are not alone. We have a vibrant community of GT patients and their caregivers who are ready to share their stories, experiences, and remedies with you.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Patient Worthy Posts on Glanzmann's Thrombathenia
Got a Minute? Learn About Glanzmann’s Thrombasthenia!
Glanzmann’s thrombasthenia (GT) is an inherited autosomal disorder that begins at birth. It causes prolonged or spontaneous bleeding and affects one out of one million people. Patients
It’s a Bloody Mess to be One in a Million
Has anyone ever called you one in a million? You took it as a compliment, no doubt. Maybe you saw this as someone saying that
March is Bleeding Disorders Awareness Month: A Primer on Platelet Disorders
To read our primer on Hemophilia, click here and to read our primer on von Willebrand click here. These next three bleeding disorders – grouped under
First Patient Dosed in MarzAA Study for Bleeding Disorders
In a news release from May 18, 2021, biopharmaceutical company Catalyst Biosciences, Inc. (“Catalyst”) shared that the first patient was dosed in the Phase
EAHAD 2024: Positive Clinical Data on HMB-001 for Glanzmann Thrombasthenia
The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders took place this year from February 6-9, 2024. During the Congress, stakeholders
